Free Trial
→ Missed the Run So Far? This Is Your Second Chance (From Crypto Swap Profits) (Ad) Free PYPD Stock Alerts

PolyPid (PYPD) News Today

PolyPid logo
$3.62 -0.18 (-4.74%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$3.64 +0.02 (+0.69%)
As of 07/18/2025 07:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

PYPD Latest News

PYPD: Positive Topline Data From D-PLEX₁₀₀ Trial Contributes to Multiple Subsequent Benefits
July 16 at 7:58 PM  |  finance.yahoo.comhttps://finance.yahoo.com/news/pypd-positive-topline-data-d-130500297.html
PolyPid Unveils a Long-Acting GLP-1 Receptor Agonists Delivery Platform Targeting the Diabetes and Weight Loss Market
July 15, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/polypid-unveils-long-acting-glp-120000158.html
PolyPid Launches Long-Acting GLP-1 Delivery Platform for Diabetes Market
July 15, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/polypid-launches-long-acting-glp-1-delivery-platform-for-diabetes-market?utm_source=marketbeat.com&utm_medium=referral
PolyPid Unveils a Long-Acting GLP-1 Receptor Agonists Delivery Platform Targeting the Diabetes and Weight Loss Market
July 15, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/07/15/3115546/0/en/polypid-unveils-a-long-acting-glp-1-receptor-agonists-delivery-platform-targeting-the-diabetes-and-weight-loss-market.html
PolyPid Ltd. (NASDAQ:PYPD) Receives $11.80 Average PT from Brokerages
July 15, 2025  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30216616
PolyPid (NASDAQ:PYPD) Upgraded by Wall Street Zen to "Hold" Rating
July 14, 2025  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30215242
PolyPid (NASDAQ:PYPD) Stock Price Down 0.6% - Time to Sell?
July 9, 2025  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30207357
PolyPid Ltd. (PYPD) Latest Stock News & Headlines - Yahoo Finance
June 26, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/quote/PYPD/news/
PolyPid Secures $26.7 Million in Additional Funding to Extend Runway Ahead of D-PLEX₁₀₀ FDA Approval
June 18, 2025  |  nasdaq.comhttps://www.nasdaq.com/articles/polypid-secures-267-million-additional-funding-extend-runway-ahead-d-plex100-fda-approval
PolyPid Secures $26.7 Million Through Warrant Exercise Following Successful SHIELD II Phase 3 Trial Results
June 16, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/06/16/3100290/0/en/polypid-secures-26-7-million-through-warrant-exercise-following-successful-shield-ii-phase-3-trial-results.html
PESG Research Update: PolyPid's SHIELD II Trial Delivers Transformative Phase 3 Topline Results - Paradigm Shift in Surgical Infection Prevention
June 11, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/06/11/3097659/0/en/pesg-research-update-polypid-s-shield-ii-trial-delivers-transformative-phase-3-topline-results-paradigm-shift-in-surgical-infection-prevention.html
PESG Research Update: PolyPid SHIELD's II Delivers Transformative Phase 3 Topline Results - Paradigm Shift in Surgical Infection Prevention
June 11, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/06/11/3097652/0/en/pesg-research-update-polypid-shield-s-ii-delivers-transformative-phase-3-topline-results-paradigm-shift-in-surgical-infection-prevention.html
PolyPid Announces Positive Topline Results from Phase 3 SHIELD II Trial: D-PLEX₁₀₀ Demonstrated Significant Reduction in Surgical Site Infections and Successfully Met ...
June 11, 2025  |  seekingalpha.comhttps://seekingalpha.com/pr/20129886-polypid-announces-positive-topline-results-from-phase-3-shield-ii-trial-d-plex-demonstrated
Craig-Hallum Reaffirms Their Buy Rating on PolyPid (PYPD)
June 11, 2025  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/PYPD/pressreleases/32805530/craig-hallum-reaffirms-their-buy-rating-on-polypid-pypd/
Nano-Cap PolyPid's Lead Drug Candidate Cuts Surgical Infection Risk by 38% In Phase 3 Trial
June 11, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/nano-cap-polypids-lead-drug-165314607.html
PolyPid price target raised to $13 from $11 at H.C. Wainwright
June 11, 2025  |  msn.comhttps://www.msn.com/en-us/money/markets/polypid-price-target-raised-to-13-from-11-at-hc-wainwright/ar-AA1GnJXr
PolyPid shares surge on successful D-PLEX100 trial results
June 9, 2025  |  in.investing.comhttps://in.investing.com/news/stock-market-news/polypid-shares-surge-on-successful-dplex100-trial-results-93CH-4868475
BriefCast Publishes Transcript: PolyPid Ltd. SHIELD II Phase 3 Trial Topline Results Call Transcript
June 9, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/06/09/3095850/0/en/briefcast-publishes-transcript-polypid-ltd-shield-ii-phase-3-trial-topline-results-call-transcript.html
PolyPid’s D-PLEX100 Achieves Positive Phase 3 Results in SHIELD II Trial
June 9, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/polypids-d-plex100-achieves-positive-phase-3-results-in-shield-ii-trial?utm_source=marketbeat.com&utm_medium=referral
PolyPid Announces Positive Topline Results from Phase 3 SHIELD II Trial: D-PLEX₁₀₀ Demonstrated Significant Reduction in Surgical Site Infections and Successfully Met Primary and All Key Secondary Endpoints
June 9, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/06/09/3095757/0/en/polypid-announces-positive-topline-results-from-phase-3-shield-ii-trial-d-plex-demonstrated-significant-reduction-in-surgical-site-infections-and-successfully-met-primary-and-all-k.html
PolyPid to Host Conference Call and Webcast to Discuss D-PLEX₁₀₀ SHIELD II Phase 3 Trial Topline Results on Monday, June 9, 2025
June 8, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/polypid-host-conference-call-webcast-200500002.html
PolyPid to Host Conference Call and Webcast to Discuss D-PLEX₁₀₀ SHIELD II Phase 3 Trial Topline Results on Monday, June 9, 2025
June 6, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/06/06/3095438/0/en/PolyPid-to-Host-Conference-Call-and-Webcast-to-Discuss-D-PLEX-SHIELD-II-Phase-3-Trial-Topline-Results-on-Monday-June-9-2025.html
Roth Capital Initiates Coverage of PolyPid (PYPD) with Buy Recommendation
June 6, 2025  |  msn.comhttps://www.msn.com/en-us/technology/general/roth-capital-initiates-coverage-of-polypid-pypd-with-buy-recommendation/ar-AA1Gc18X
PolyPid at Lytham Partners: Strategic Advances and Financial Stability
May 30, 2025  |  investing.comhttps://www.investing.com/news/transcripts/polypid-at-lytham-partners-strategic-advances-and-financial-stability-93CH-4070935
PESG Research Report: Revolutionary Surgical Infection Prevention: PolyPid's D-PLEX100 Approaches Critical Phase 3 Data Readout
May 30, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/05/30/3091148/0/en/pesg-research-report-revolutionary-surgical-infection-prevention-polypid-s-d-plex100-approaches-critical-phase-3-data-readout.html
PolyPid to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
May 20, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/05/20/3084687/0/en/polypid-to-participate-in-the-lytham-partners-spring-2025-investor-conference-on-may-29-2025.html
PolyPid Ltd (PYPD) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
May 16, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/polypid-ltd-pypd-q1-2025-071041470.html
PolyPid Ltd. (NASDAQ:PYPD) Q1 2025 Earnings Call Transcript
May 16, 2025  |  msn.comhttps://www.msn.com/en-us/money/savingandinvesting/polypid-ltd-nasdaq-pypd-q1-2025-earnings-call-transcript/ar-AA1EPF3F
PolyPid Ltd. (PYPD) Q1 2025 Earnings Call Transcript
May 14, 2025  |  seekingalpha.comhttps://seekingalpha.com/article/4786701-polypid-ltd-pypd-q1-2025-earnings-call-transcript
PolyPid Completes Enrollment in Phase 3 Trial of D-PLEX100
May 14, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/polypid-completes-enrollment-in-phase-3-trial-of-d-plex100?utm_source=marketbeat.com&utm_medium=referral
PolyPid Provides Corporate Update and Reports First Quarter 2025 Financial Results
May 14, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/05/14/3080990/0/en/polypid-provides-corporate-update-and-reports-first-quarter-2025-financial-results.html
A Look Ahead: PolyPid's Earnings Forecast
May 13, 2025  |  benzinga.comhttps://www.benzinga.com/insights/earnings/25/05/45387275/a-look-ahead-polypids-earnings-forecast
PolyPid to Report First Quarter 2025 Financial Results and Operational Highlights on May 14, 2025
April 29, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/04/29/3070012/0/en/polypid-to-report-first-quarter-2025-financial-results-and-operational-highlights-on-may-14-2025.html
PolyPid to Participate in The Citizens Life Sciences Conference
April 22, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/04/22/3065364/0/en/polypid-to-participate-in-the-citizens-life-sciences-conference.html
PolyPid management to meet with Oppenheimer
April 17, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/polypid-management-to-meet-with-oppenheimer-1034596528
Barclays Reaffirms Their Hold Rating on PolyPid (PYPD)
March 24, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/barclays-reaffirms-their-hold-rating-on-polypid-pypd-1034507373
PolyPid completes enrollment in SHIELD II Phase 3 trial for D-PLEX100
March 12, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/polypid-completes-enrollment-in-shield-ii-phase-3-trial-for-d-plex100-1034463296
Craig-Hallum Remains a Buy on PolyPid (PYPD)
March 12, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/craig-hallum-remains-a-buy-on-polypid-pypd-1034464302
PolyPid Completes Enrollment in Phase 3 Trial for Surgical Infection Prevention
March 11, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/polypid-completes-enrollment-in-phase-3-trial-for-surgical-infection-prevention?utm_source=marketbeat.com&utm_medium=referral
PolyPid Announces Successful Completion of Enrollment in Phase 3 SHIELD II Trial of D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections
March 11, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/03/11/3040420/0/en/polypid-announces-successful-completion-of-enrollment-in-phase-3-shield-ii-trial-of-d-plex-for-the-prevention-of-abdominal-colorectal-surgical-site-infections.html
PolyPid to Participate in the 37th Annual ROTH Conference
March 3, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/03/03/3035457/0/en/polypid-to-participate-in-the-37th-annual-roth-conference.html
PolyPid Ltd (PYPD) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Rising R&D Costs
February 13, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/polypid-ltd-pypd-q4-2024-070947025.html
PolyPid targets SHIELD II trial completion with top-line results in Q2 2025
February 12, 2025  |  msn.comhttps://www.msn.com/en-us/money/savingandinvesting/polypid-targets-shield-ii-trial-completion-with-top-line-results-in-q2-2025/ar-AA1yUql9
PolyPid (PYPD) Gets a Buy from JMP Securities
February 12, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/polypid-pypd-gets-a-buy-from-jmp-securities-1034350414
PolyPid Ltd. (PYPD) Q4 2024 Earnings Call Transcript
February 12, 2025  |  seekingalpha.comhttps://seekingalpha.com/article/4757428-polypid-ltd-pypd-q4-2024-earnings-call-transcript
PolyPid Updates: New Board Appointment and SHIELD II Trial Progress
February 12, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/polypid-updates-new-board-appointment-and-shield-ii-trial-progress?utm_source=marketbeat.com&utm_medium=referral
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results
February 12, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/02/12/3024905/0/en/polypid-provides-corporate-update-and-reports-fourth-quarter-and-full-year-2024-financial-results.html
Craig-Hallum Sticks to Its Buy Rating for PolyPid (PYPD)
February 10, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/craig-hallum-sticks-to-its-buy-rating-for-polypid-pypd-1034335478
PolyPid to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
January 30, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/01/30/3017860/0/en/polypid-to-participate-in-the-oppenheimer-35th-annual-healthcare-life-sciences-conference.html
PolyPid to Report Fourth Quarter and Full-Year 2024 Financial Results and Operational Highlights on February 12, 2025
January 29, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/01/29/3017023/0/en/polypid-to-report-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-12-2025.html
Get PolyPid News Delivered to You Automatically

Sign up to receive the latest news and ratings for PYPD and its competitors with MarketBeat's FREE daily newsletter.

PYPD Media Mentions By Week

PYPD Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PYPD
News Sentiment
▼
0.08

0.57
▲
Average
Medical
News Sentiment

PYPD News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PYPD Articles
This Week
▼
6

1
▲
PYPD Articles
Average Week

Get PolyPid News Delivered to You Automatically

Sign up to receive the latest news and ratings for PYPD and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies
Headlines Tools

This page (NASDAQ:PYPD) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
Google did what!?!?
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...
Stansberry Research | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump c...
Weiss Ratings | Sponsored
Elon’s NEXT Big IPO?
Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...
Banyan Hill Publishing | Sponsored
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...
Brownstone Research | Sponsored